✦ LIBER ✦

Poor long-term results from low-dose methotrexate therapy in rheumatoid arthritis

✍ Scribed by Oliver Fitzgerald; John Hanly; Jack Molony; Barry Bresnihan

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 224 KB
Volume: 27
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780270525

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of long-term methotrexate the

The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis

✍ David J. Bjorkman; Mark Boschert; Keith G. Tolman; Daniel O. Clegg; John R. Ward 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB 👁 2 views

Methotrexate polyglutamate concentration

Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy

✍ Lisa K. Stamp; John L. O'Donnell; Peter T. Chapman; Mei Zhang; Jill James; Chris 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

Long-term efficacy and safety of etanerc

Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open-label, extended-treatment trial

✍ Daniel J. Lovell; Edward H. Giannini; Andreas Reiff; Olcay Y. Jones; Rayfel Schn 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

Ultrasonographic and radiographic result

Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year–delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis

✍ P. C. Taylor; A. Steuer; J. Gruber; C. McClinton; D. O. Cosgrove; M. J. K. Bloml 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

Very early treatment with infliximab in

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve-month randomized, double-blind, placebo-controlled trial

✍ Mark A. Quinn; Philip G. Conaghan; Philip J. O'Connor; Zunaid Karim; Adam Greens 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views